MedTrace Logo

Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy

NCT01803191 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 461

Last updated 2017-12-13

No results posted yet for this study

Summary

The purpose of this clinical trial is compare the incidence of symptomatic or asymptomatic bacteriuria after transrectal ultrasound guided prostate biopsy using a single dose of fosfomycin 3 g one hour before the biopsy compared to observed with the use of a single dose of ciprofloxacin 500 mg 1 hour before biopsy.

Conditions

Interventions

DRUG

Fosfomycin 3 g

Unique oral dosis of fosfomycin 1 hour before biopsy

DRUG

Ciprofloxacin 500 mg

Unique oral dosis of ciprofloxacin 500 mg, 1 hour before biopsy

Sponsors & Collaborators

  • Hospital General Universitario Santa Lucía

    collaborator OTHER

  • Hospital General Universitario Los Arcos del Mar Menor

    collaborator OTHER

  • Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

    lead OTHER

Principal Investigators

  • Pedro PL Lopez Cubillana, MD · Hospital Universitario Virgen de la Arrixaca

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2016-01-25
Completion
2016-01-25

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01803191 on ClinicalTrials.gov